3-((1S)-1,5-Dimethyl-4-hexenyl)-6-methylene-1-cyclohexene, (3R)-

Details

Top
Internal ID 055eb101-3459-4042-9dea-63e2469089fc
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (3S)-3-(6-methylhept-5-en-2-yl)-6-methylidenecyclohexene
SMILES (Canonical) CC(CCC=C(C)C)C1CCC(=C)C=C1
SMILES (Isomeric) CC(CCC=C(C)C)[C@@H]1CCC(=C)C=C1
InChI InChI=1S/C15H24/c1-12(2)6-5-7-14(4)15-10-8-13(3)9-11-15/h6,8,10,14-15H,3,5,7,9,11H2,1-2,4H3/t14?,15-/m0/s1
InChI Key PHWISBHSBNDZDX-LOACHALJSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24
Molecular Weight 204.35 g/mol
Exact Mass 204.187800766 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 5.40
Atomic LogP (AlogP) 4.89
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 4

Synonyms

Top
3-((1S)-1,5-Dimethyl-4-hexenyl)-6-methylene-1-cyclohexene, (3R)-
PHWISBHSBNDZDX-LOACHALJSA-N

2D Structure

Top
2D Structure of 3-((1S)-1,5-Dimethyl-4-hexenyl)-6-methylene-1-cyclohexene, (3R)-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9905 99.05%
Caco-2 + 0.9298 92.98%
Blood Brain Barrier + 1.0000 100.00%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Lysosomes 0.3961 39.61%
OATP2B1 inhibitior - 0.8575 85.75%
OATP1B1 inhibitior + 0.9136 91.36%
OATP1B3 inhibitior + 0.8915 89.15%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.7750 77.50%
BSEP inhibitior - 0.7773 77.73%
P-glycoprotein inhibitior - 0.9663 96.63%
P-glycoprotein substrate - 0.8880 88.80%
CYP3A4 substrate - 0.5654 56.54%
CYP2C9 substrate - 0.8164 81.64%
CYP2D6 substrate - 0.7751 77.51%
CYP3A4 inhibition - 0.9155 91.55%
CYP2C9 inhibition - 0.8744 87.44%
CYP2C19 inhibition - 0.8653 86.53%
CYP2D6 inhibition - 0.9414 94.14%
CYP1A2 inhibition - 0.7209 72.09%
CYP2C8 inhibition - 0.9666 96.66%
CYP inhibitory promiscuity - 0.6482 64.82%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.6700 67.00%
Carcinogenicity (trinary) Warning 0.5271 52.71%
Eye corrosion + 0.5313 53.13%
Eye irritation + 0.5518 55.18%
Skin irritation + 0.7473 74.73%
Skin corrosion - 0.9774 97.74%
Ames mutagenesis - 0.8800 88.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7424 74.24%
Micronuclear - 1.0000 100.00%
Hepatotoxicity + 0.5250 52.50%
skin sensitisation + 0.9332 93.32%
Respiratory toxicity + 0.5222 52.22%
Reproductive toxicity - 0.6222 62.22%
Mitochondrial toxicity - 0.8375 83.75%
Nephrotoxicity - 0.7733 77.33%
Acute Oral Toxicity (c) III 0.9084 90.84%
Estrogen receptor binding - 0.9581 95.81%
Androgen receptor binding - 0.8010 80.10%
Thyroid receptor binding - 0.5790 57.90%
Glucocorticoid receptor binding - 0.5401 54.01%
Aromatase binding - 0.8321 83.21%
PPAR gamma - 0.7241 72.41%
Honey bee toxicity - 0.9077 90.77%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.7200 72.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.46% 91.11%
CHEMBL2581 P07339 Cathepsin D 91.54% 98.95%
CHEMBL3359 P21462 Formyl peptide receptor 1 90.25% 93.56%
CHEMBL221 P23219 Cyclooxygenase-1 85.98% 90.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.81% 96.09%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.45% 95.89%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 85.44% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.37% 100.00%
CHEMBL1977 P11473 Vitamin D receptor 84.28% 99.43%
CHEMBL226 P30542 Adenosine A1 receptor 82.79% 95.93%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.65% 97.09%
CHEMBL1937 Q92769 Histone deacetylase 2 81.00% 94.75%
CHEMBL253 P34972 Cannabinoid CB2 receptor 80.99% 97.25%
CHEMBL264 Q9Y5N1 Histamine H3 receptor 80.89% 91.43%

Cross-Links

Top
PubChem 91746521
NPASS NPC105557